Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Total Liabilities
Based on the latest financial reports, Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has total liabilities worth CN¥1.96 Billion CNY (≈ $287.22 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300026 operating cash flow to assess how effectively this company generates cash.
Tianjin Chase Sun Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Tianjin Chase Sun Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 300026 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Tianjin Chase Sun Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tianjin Chase Sun Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CEAT Limited
NSE:CEATLTD
|
India | Rs85.22 Billion |
|
Arteche Lantegi Elkartea SA
MC:ART
|
Spain | €347.10 Million |
|
DOMS Industries Limited
NSE:DOMS
|
India | Rs4.21 Billion |
|
Xianheng International Science & Technology Co Ltd
SHG:605056
|
China | CN¥1.35 Billion |
|
Killam Apartment Real Estate Investment Trust
TO:KMP-UN
|
Canada | CA$2.44 Billion |
|
Harbin Electric Coporation Jiamusi Electric Machine Co Ltd
SHE:000922
|
China | CN¥4.54 Billion |
|
SoftwareONE Holding AG
SW:SWON
|
Switzerland | CHF4.45 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Tianjin Chase Sun Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Tianjin Chase Sun Pharmaceutical Co Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tianjin Chase Sun Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.37 Billion ≈ $346.30 Million |
-20.24% |
| 2023-12-31 | CN¥2.97 Billion ≈ $434.20 Million |
-28.80% |
| 2022-12-31 | CN¥4.17 Billion ≈ $609.88 Million |
+14.03% |
| 2021-12-31 | CN¥3.65 Billion ≈ $534.83 Million |
+31.11% |
| 2020-12-31 | CN¥2.79 Billion ≈ $407.94 Million |
+105.55% |
| 2019-12-31 | CN¥1.36 Billion ≈ $198.46 Million |
+49.43% |
| 2018-12-31 | CN¥907.61 Million ≈ $132.81 Million |
-1.31% |
| 2017-12-31 | CN¥919.62 Million ≈ $134.57 Million |
-26.00% |
| 2016-12-31 | CN¥1.24 Billion ≈ $181.84 Million |
+5.07% |
| 2015-12-31 | CN¥1.18 Billion ≈ $173.07 Million |
+72.69% |
| 2014-12-31 | CN¥684.85 Million ≈ $100.22 Million |
+32.62% |
| 2013-12-31 | CN¥516.40 Million ≈ $75.57 Million |
+24.38% |
| 2012-12-31 | CN¥415.19 Million ≈ $60.76 Million |
+16.15% |
| 2011-12-31 | CN¥357.47 Million ≈ $52.31 Million |
+96.26% |
| 2010-12-31 | CN¥182.14 Million ≈ $26.65 Million |
+35.02% |
| 2009-12-31 | CN¥134.90 Million ≈ $19.74 Million |
+47.22% |
| 2008-12-31 | CN¥91.63 Million ≈ $13.41 Million |
-19.47% |
| 2007-12-31 | CN¥113.79 Million ≈ $16.65 Million |
+34.91% |
| 2006-12-31 | CN¥84.34 Million ≈ $12.34 Million |
-- |
About Tianjin Chase Sun Pharmaceutical Co Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves th… Read more